Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro

References

• American Cancer SocietyCancer Facts & Figures 2015Atlanta, GAAmerican Cancer Society2015
   Google Scholar
• RossouwJEAndersonGLPrenticeRLWriting Group for the Women’s Health Initiative InvestigatorsRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trialJAMA2002288332133312117397
   PubMed Web of Science ®Google Scholar
• BeralVMillion Women Study CBreast cancer and hormone-replacement therapy in the Million Women StudyLancet2003362938241942712927427
   PubMed Web of Science ®Google Scholar
• ChlebowskiRTHendrixSLLangerRDWHI InvestigatorsInfluence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women’s Health Initiative randomized trialJAMA2003289243243325312824205
   PubMed Web of Science ®Google Scholar
• RossRKPaganini-HillAWanPCPikeMCEffect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestinJ Natl Cancer Inst200092432833210675382
   PubMed Web of Science ®Google Scholar
• KimJJKuritaTBulunSEProgesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancerEndocr Rev201334113016223303565
   PubMed Web of Science ®Google Scholar
• HolmbergLIversenOERudenstamCMHABITS Study GroupIncreased risk of recurrence after hormone replacement therapy in breast cancer survivorsJ Natl Cancer Inst2008100747548218364505
   PubMedGoogle Scholar
• HyderSMChiappettaCStancelGMPharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cellsInt J Cancer200192446947311304678
   PubMed Web of Science ®Google Scholar
• HyderSMMurthyLStancelGMProgestin regulation of vascular endothelial growth factor in human breast cancer cellsCancer Res19985833923959458078
   PubMed Web of Science ®Google Scholar
• JengMHParkerCJJordanVCEstrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferationCancer Res19925223653965461423300
   PubMed Web of Science ®Google Scholar
• LiangYHyderSMProliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effectsEndocrinology200514683632364115845615
   PubMed Web of Science ®Google Scholar
• MirkinSWongBCArcherDFEffect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cellsFertil Steril200584248549116084894
   PubMed Web of Science ®Google Scholar
• LiangYBesch-WillifordCBrekkenRAHyderSMProgestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeuticsCancer Res200767209929993617942925
   PubMed Web of Science ®Google Scholar
• BenakanakereIBesch-WillifordCSchnellJNatural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley ratsClin Cancer Res200612134062407116818706
   PubMed Web of Science ®Google Scholar
• LiangYBenakanakereIBesch-WillifordCHyderRSEllersieckMRHyderSMSynthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude miceMenopause20101751040104720461021
   PubMed Web of Science ®Google Scholar
• FuXDGirettiMSBaldacciCExtra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeletonPLoS One200837e279018665217
   PubMed Web of Science ®Google Scholar
• PolyakKHeterogeneity in breast cancerJ Clin Invest2011121103786378821965334
   PubMed Web of Science ®Google Scholar
• GinestierCHurMHCharafe-JauffretEALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeCell Stem Cell20071555556718371393
   PubMed Web of Science ®Google Scholar
• ChenKHuangYHChenJLUnderstanding and targeting cancer stem cells: therapeutic implications and challengesActa Pharmacol Sin201334673274023685952
   PubMed Web of Science ®Google Scholar
• ChafferCLWeinbergRAA perspective on cancer cell metastasisScience201133160241559156421436443
   PubMed Web of Science ®Google Scholar
• O’BrienCAKresoAJamiesonCHCancer stem cells and self-renewalClin Cancer Res201016123113312020530701
   PubMed Web of Science ®Google Scholar
• TanBTParkCYAillesLEWeissmanILThe cancer stem cell hypothesis: a work in progressLab Invest200686121203120717075578
   PubMed Web of Science ®Google Scholar
• ZhengSXinLLiangAFuYCancer stem cell hypothesis: a brief summary and two proposalsCytotechnology201365450551223250634
   PubMed Web of Science ®Google Scholar
• AxlundSDSartoriusCAProgesterone regulation of stem and progenitor cells in normal and malignant breastMol Cell Endocrinol20123571–2717921945473
   PubMed Web of Science ®Google Scholar
• JoshiPAJacksonHWBeristainAGProgesterone induces adult mammary stem cell expansionNature2010465729980380720445538
   PubMed Web of Science ®Google Scholar
• Finlay-SchultzJSartoriusCASteroid hormones, steroid receptors, and breast cancer stem cellsJ Mammary Gland Biol Neoplasia2015201–2395026265122
   PubMed Web of Science ®Google Scholar
• HorwitzKBSartoriusCAProgestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesisJ Clin Endocrinol Metab20089393295329818647813
   PubMed Web of Science ®Google Scholar
• PontaHShermanLHerrlichPACD44: from adhesion molecules to signalling regulatorsNat Rev Mol Cell Biol200341334512511867
   PubMed Web of Science ®Google Scholar
• SartoriusCAGroshongSDMillerLANew T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMPCancer Res19945414386838778033109
   PubMed Web of Science ®Google Scholar
• SubikKLeeJFBaxterLThe expression patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell linesBreast Cancer (Auckl)20104354120697531
   PubMedGoogle Scholar
• SunYFangMDaviesHHuZMifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid propertiesGynecol Endocrinol201430316917324205903
   PubMed Web of Science ®Google Scholar
• HeikinheimoOKekkonenRLahteenmakiPThe pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin actionContraception200368642142614698071
   PubMed Web of Science ®Google Scholar
• ZöllerMCD44: can a cancer-initiating cell profit from an abundantly expressed molecule?Nat Rev Cancer201111425426721390059
   PubMed Web of Science ®Google Scholar
• BourguignonLYWongGEarleCChenLHyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinomaJ Biol Chem201228739328003282422847005
   PubMed Web of Science ®Google Scholar
• SobellHMActinomycin and DNA transcriptionProc Natl Acad Sci U S A19858216532853312410919
   PubMed Web of Science ®Google Scholar
• WangRLvQMengWComparison of mammosphere formation from breast cancer cell lines and primary breast tumorsJ Thorac Dis20146682983724977009
   PubMed Web of Science ®Google Scholar
• PattabiramanDRWeinbergRATackling the cancer stem cells – what challenges do they pose?Nat Rev Drug Discov201413749751224981363
   PubMed Web of Science ®Google Scholar
• VidalSJRodriguez-BravoVGalskyMCordon-CardoCDomingo-DomenechJTargeting cancer stem cells to suppress acquired chemotherapy resistanceOncogene201433364451446324096485
   PubMed Web of Science ®Google Scholar
• LiYRogoffHAKeatesSSuppression of cancer relapse and metastasis by inhibiting cancer stemnessProc Natl Acad Sci U S A201511261839184425605917
   PubMed Web of Science ®Google Scholar
• LiLBhatiaRStem cell quiescenceClin Cancer Res201117154936494121593194
   PubMed Web of Science ®Google Scholar
• YanYZuoXWeiDConcise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic targetStem cells translational medicine2015491033104326136504
   PubMed Web of Science ®Google Scholar
• WilliamsKMotianiKGiridharPVKasperSCD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic nichesExp Biol Med20132383324338
   PubMed Web of Science ®Google Scholar
• BourguignonLYEarleCWongGSpevakCCKruegerKStem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cellsOncogene201231214916021685938
   PubMed Web of Science ®Google Scholar
• GrahamJDClarkeCLExpression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cellsBreast Cancer Res20024518719012223122
   PubMed Web of Science ®Google Scholar
• HyderSMNawazZChiappettaCStancelGMIdentification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factorCancer Res200060123183319010866309
   PubMed Web of Science ®Google Scholar
• TakahashiRUMiyazakiHTakeshitaFLoss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1Nat Commun20156731826065921
   PubMed Web of Science ®Google Scholar
• CittellyDMFinlay-SchultzJHoweENProgestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4Oncogene201332202555256422751119
   PubMed Web of Science ®Google Scholar
• BourguignonLYSingletonPAZhuHZhouBHyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cellsJ Biol Chem200227742397033971212145287
   PubMed Web of Science ®Google Scholar
• WangMLChiouSHWuCWTargeting cancer stem cells: emerging role of Nanog transcription factorOnco Targets Ther201361207122024043946
   PubMed Web of Science ®Google Scholar
• WangSJBourguignonLYRole of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistanceAm J Pathol2011178395696321356346
   PubMed Web of Science ®Google Scholar
• WangSJWongGde HeerAMXiaWBourguignonLYCD44 variant isoforms in head and neck squamous cell carcinoma progressionLaryngoscope200911981518153019507218
   PubMed Web of Science ®Google Scholar
• WangSJWreesmannVBBourguignonLYAssociation of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancerHead Neck200729655055817252589
   PubMed Web of Science ®Google Scholar